Astera Labs vs Penguin Solutions
ALAB and PENG side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALAB and PENG compare
Astera Labs is the larger company, worth 13 times as much as Penguin Solutions ($38.5B against $2.9B).
On earnings, Penguin Solutions is cheaper: it trades at 18.2× trailing earnings, against 88.4× for Astera Labs.
Astera Labs grew revenue faster over the last twelve months (115% versus 26.5% for Penguin Solutions).
Astera Labs keeps more of each dollar of sales as profit, with a net margin of 29.6% compared with 10.4% at Penguin Solutions.
Penguin Solutions scores higher on the StockData Score (14 against 12 for Astera Labs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALAB | PENG |
|---|---|---|
| Size and price | ||
| Market cap | $38.5B | $2.9B |
| Share price | $221.83 | $47.36 |
| Change, 1 year | 40.6% | 128% |
| Change, 5 years | – | 63.1% |
| Beta (5Y) | 2.98 | 2.12 |
| Employees | 756 | 2,800 |
| StockData Score | ||
| Total score | 12 | 14 (better) |
| Valuation score | 0 | 5 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 4 | 5 (better) |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 88.4× | 18.2× (better) |
| P/S | 24.7× | 1.6× (better) |
| P/B | 19.2× | 5.5× (better) |
| EV/EBITDA | 89.9× | 14.0× (better) |
| P/FCF | 112× | – |
| FCF yield | 0.90% (better) | −5.7% |
| Fair value | $72.25 | $78.50 |
| Margin of safety | −207% | 39.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 115% (better) | 26.5% |
| Revenue growth, 5Y average | – | 10.4% |
| Net income growth (TTM) | 132% | 611% (better) |
| EPS growth (TTM) | – | 829% |
| EPS growth, 5Y average | – | 42.7% |
| Profitability | ||
| Gross margin | 73.9% (better) | 27.7% |
| Operating margin | 25.5% (better) | 9.6% |
| Net margin | 29.6% (better) | 10.4% |
| FCF margin | 22.1% (better) | −9.4% |
| Return on equity | 28.2% | 39.5% (better) |
| Return on invested capital | 105% (better) | 31.1% |
| Financial health | ||
| Debt / equity | 0.00 | 1.52 (better) |
| Net debt / EBITDA | – | 0.66 |
| Current ratio | 8.03 (better) | 1.88 |
| Altman Z-score | 79.15 (better) | 2.22 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | – | 2.2% |
| Shareholder yield | 0.00% | 2.2% (better) |
| Ownership | ||
| Held by institutions | 73.6% | 95.1% |
| Held by insiders | 11.4% | 14.2% |
| Insider net buying, 12 months | −$758M | −$5.0M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.2% | 12.4% |
Go deeper
- ALAB stock overview
- ALAB income statement
- ALAB valuation and score
- PENG stock overview
- PENG income statement
- PENG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.